Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/2014
10/30/2014US20140323433 Method for rehydrating polysaccharide particles
10/30/2014US20140323432 Cartilage production promoter and prophylactic or therapeutic agent for diseases associated with cartilage damage
10/30/2014US20140323430 Use of bacterial endotoxins and lipoteichoic acids to improve postpartal health and productivity of dairy cows and their newborns
10/30/2014US20140323429 Nsaids-induced gastrointestinal mucosal disorder alleviator and manufacturing method thereof
10/30/2014US20140323428 Antineuritic pharmaceutical combination and compositions
10/30/2014US20140323427 Uridine and uridine analogues for treatment of specific lung diseases, namely copd and pulmonary fibrosis
10/30/2014US20140323426 Use of opioid antagonists to attenuate endothelial cell proliferation and migration
10/30/2014US20140323425 Nucleoside analogues for the treatment of a viral infection, and method for evaluating the sensitivity to said treatment
10/30/2014US20140323424 Methods for assessment and treatment of mood disorders via single nucleotide polymorphisms analysis
10/30/2014US20140323423 Biosynchronous transdermal drug delivery for longevity, anti-aging, fatigue management, obesity, weight loss, weight management, delivery of nutraceuticals, and the treatment of hyperglycemia, alzheimer's disease, sleep disorders...
10/30/2014US20140323422 Anionic Conjugates of Glycosylated Bacterial Metabolite
10/30/2014US20140323421 Combination Therapy for Treating Cancer
10/30/2014US20140323420 Reducing transmission of sexually transmitted infections
10/30/2014US20140323419 High efficacy combination therapy for helicobacter pylori eradication and packaging for the distribution and use thereof
10/30/2014US20140323413 Methods of diagnosing and treating vascular associated maculopathy and symptoms thereof
10/30/2014US20140323412 Bile acid recycling inhibitors for treatment of hypercholemia and cholestatic liver disease
10/30/2014US20140323409 Apotransferrin for the treatment of brain stroke
10/30/2014US20140323399 Compositions and methods for increasing insulin sensitivity
10/30/2014US20140323395 Methods for Treating HCV
10/30/2014US20140322812 Mutant Receptors and Their Use in a Nuclear Receptor-Based Inducible Gene Expression System
10/30/2014US20140322407 Medium chain peroxycarboxylic acid compositions
10/30/2014US20140322372 Bacterial Ribonucleic Acid Cell Wall Compositions and Methods of Making and Using Them
10/30/2014US20140322371 Bixa orellana composition for treating macular degeneration
10/30/2014US20140322368 Method of reducing and improving the appearance of scar tissue
10/30/2014US20140322366 hTRPA1-ACTIVATING COMPOSITION AND USE THEREOF
10/30/2014US20140322357 L-arabinose plus chromium for controlling the metabolization of sucrose
10/30/2014US20140322355 Heterocyclic modulators of lipid synthesis
10/30/2014US20140322351 Biofilm-removing antimicrobial compositions and uses thereof
10/30/2014US20140322349 Microbicidal composition comprising hydrogen peroxide and aminocarboxylic acids
10/30/2014US20140322345 Novel slow-releasing ophthalmic compositions comprising povidone iodine
10/30/2014US20140322343 Sustained-release formulations of topiramate
10/30/2014US20140322342 Co-encapsulation of live cells with oxygen-generating particles
10/30/2014US20140322341 Novel hemostatic patch and uses thereof
10/30/2014US20140322340 Protein-polysaccharide conjugates and use for encapsulating nutraceuticals for clear beverage applications
10/30/2014US20140322338 Flurbiprofen formulations
10/30/2014US20140322331 Calcipotriol monohydrate nanocrystals
10/30/2014US20140322330 Methods for forming miniemulsions and use thereof for delivering bioactive agents
10/30/2014US20140322329 Multipurpose gel for vaginal dryness with direct and delayed effect
10/30/2014US20140322328 Dry powder formulations and methods of use
10/30/2014US20140322327 Drug delivery system for sustained delivery of bioactive agents
10/30/2014US20140322326 Particles comprising a releasable dopant therein
10/30/2014US20140322323 Pharmaceutical dosage form
10/30/2014US20140322321 Tablet capable of combatting misuse by injection
10/30/2014US20140322320 Novel compositions for emesis control in cancer patients undergoing chemotherapy and methods thereof
10/30/2014US20140322319 Pharmaceutical compositions
10/30/2014US20140322318 Methods for administering weight loss medications
10/30/2014US20140322317 Controlled release compositions
10/30/2014US20140322316 Optimal Colon Targeting Technology
10/30/2014US20140322315 Cysteamine and/or cystamine for treating ischemic injury
10/30/2014US20140322314 Omega-3 Fatty Acid Formulations for Use as Pharmaceutical Treatment
10/30/2014US20140322313 Pharmaceutical compositions of ibuprofen and an h2 receptor antagonist
10/30/2014US20140322312 Proton pump-inhibitor-containing capsules which comprise subunits differently structured for a delayed release of the active ingredient
10/30/2014US20140322310 Gel compositions
10/30/2014US20140322309 Alpha-aminoamidine polymers and uses thereof
10/30/2014US20140322305 Sustained release enhanced lipolytic formulation for regional adipose tissue treatment
10/30/2014US20140322304 Compositions and methods relating to proliferative diseases
10/30/2014US20140322303 Liposomal curcumin for treatment of diseases
10/30/2014US20140322300 Patch
10/30/2014US20140322299 Controlled Release of Active Using pH
10/30/2014US20140322298 Stable transdermal amphetamine compositions and methods of manufacture
10/30/2014US20140322296 Piperaquine microcapsules and compositions containing them
10/30/2014US20140322293 Methods for treating conditions of the nail unit
10/30/2014US20140322292 Insulin-mimetics as therapeutic adjuncts for bone regeneration
10/30/2014US20140322287 Bioactive coatings
10/30/2014US20140322284 Transdermal administration of tamsulosin
10/30/2014US20140322278 Modulation of Tissue Transglutaminase Activation in Disease
10/30/2014US20140322247 Cell proliferation inhibitors and conjugates thereof
10/30/2014US20140322242 Materials and methods for the prevention and treatment of cancer
10/30/2014US20140322237 Neurodegenerative diseases and methods of modeling
10/30/2014US20140322232 Methods of administering anti-tnfalpha antibodies
10/30/2014US20140322231 Osteoprotegerin in neuroprotection
10/30/2014US20140322229 Heterocyclic amides compounds which are hdac6 inhibitors and used as anti-tumoral agents
10/30/2014US20140322225 Anti-Adrenomedullin (ADM) antibody or anti-ADM antibody fragment or anti-ADM non-Ig scaffold for use in therapy of an acute disease or acute condition of a patient for stabilizing the circulation
10/30/2014US20140322213 Pharmaceutical Composition for the Treatment of Type-1 Diabetes
10/30/2014US20140322211 Tenascin-c and use thereof in rheumatoid arthritis
10/30/2014US20140322207 Methods of identifying critically ill patients at increased risk of development of organ failure and compounds for the treatment hereof
10/30/2014US20140322202 TREATMENT WITH ANTI ErbB2 ANTIBODIES
10/30/2014US20140322201 Methods of treating multiple myeloma using combination therapies based on anti-cs1 antibodies
10/30/2014US20140322198 Composition comprising vicenin-2 having a beneficial effect on neurological and/or cognitive function
10/30/2014US20140322195 Factor IXA Inhibitors
10/30/2014US20140322193 Therapies for Disorders of the Cornea and Conjunctiva
10/30/2014US20140322192 Proteoglycan degrading mutants for treatment of cns
10/30/2014US20140322190 Pharmaceutical Compositions and Methods for Digesting Atherosclerotic Plaques
10/30/2014US20140322189 Composition based on ubidecarenone
10/30/2014US20140322185 Sialic acid producing bacteria
10/30/2014US20140322173 Oncolytic Vaccinia Virus Combination Cancer Therapy
10/30/2014US20140322165 Inhibitors of hepatitis c virus polymerase
10/30/2014US20140322157 Bi-Functional Co-Polymer Use for Ophthalmic and Other Topical and Local Applications
10/30/2014US20140322149 Compound useful for treating cellulite
10/30/2014US20140322145 Antimicrobial composition
10/30/2014US20140322144 Alkaline compositions and their dental and medical use
10/30/2014US20140322142 Particle size reduction of an antimuscarinic compound
10/30/2014US20140322136 Methods for treating obesity
10/30/2014US20140322129 Anti-b7-h4 antibodies and immunoconjugates
10/30/2014US20140322128 Materials and Methods Useful to Induce Cell Death via Methuosis
10/30/2014US20140319720 Pharmaceutical compositions comprising rivaroxaban
10/30/2014US20140319030 Citrate-Based Dialysate Chemical Formulations
10/30/2014US20140318539 Aerosolization apparatus for inhalation profile-independent drug delivery
10/28/2014US8871983 Lipid compounds for suppression of tumorigenesis
10/28/2014US8871978 Preparation of hop acids and their derivatives
1 ... 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 ... 7860